China's delays in GMO crop approvals cost US economy $7 billion, biotech industry group says
Story Date: 6/1/2018

 

Source: Tom Polansek, GENETIC LITERACY PROJECT, 5/31/18


Delays in Chinese approvals of imported genetically modified crops have cut U.S. gross domestic product by about $7 billion over the past five years by reducing sales of crops and other goods, an industry group that represents global seed companies said on Wednesday [May 30]. The report by CropLife International indicates what is at stake for the administration of President Donald Trump as it seeks better access for U.S. GMO crops into China as part of a trade deal under discussion.

For more of this story, click here


























   Copyright © 2007 North Carolina Agribusiness Council, Inc. All Rights Reserved.
   All use of this Website is subject to our
Terms of Use Agreement and our Privacy Policy.